 | • レポートコード：MRC308GR11551 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のサルブタモール注射の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のサルブタモール注射市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– サルブタモール注射の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
サルブタモール注射市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・サルブタモール硫酸塩注射液、サルブタモール・臭化イプラトロピウム注射液
用途別セグメント
・病院、専門クリニック、治療院、その他
主要な市場プレーヤー
・Teva Pharmaceuticals、Mylan、Novartis、Pfizer、Sanofi、Merck、Johnson & Johnson、Roche、GlaxoSmithKline、AstraZeneca、Abbott Laboratories
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、サルブタモール注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なサルブタモール注射メーカーの企業概要、2019年～2022年までのサルブタモール注射の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なサルブタモール注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別サルブタモール注射の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのサルブタモール注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのサルブタモール注射市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびサルブタモール注射の産業チェーンを掲載しています。
・第14、15章では、サルブタモール注射の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– サルブタモール注射の概要
– 種類別分析（2018年vs2022年vs2029年）：サルブタモール硫酸塩注射液、サルブタモール・臭化イプラトロピウム注射液
– 用途別分析（2018年vs2022年vs2029年）：病院、専門クリニック、治療院、その他
– 世界のサルブタモール注射市場規模・予測
– 世界のサルブタモール注射生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Teva Pharmaceuticals、Mylan、Novartis、Pfizer、Sanofi、Merck、Johnson & Johnson、Roche、GlaxoSmithKline、AstraZeneca、Abbott Laboratories
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：サルブタモール硫酸塩注射液、サルブタモール・臭化イプラトロピウム注射液
・用途別分析2018年-2029年：病院、専門クリニック、治療院、その他
・サルブタモール注射の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・サルブタモール注射のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・サルブタモール注射のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・サルブタモール注射の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・サルブタモール注射の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Salbutamol Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Salbutamol Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Salbutamol Sulfate Injection
1.3.3 Salbutamol and Ipratropium Bromide Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Salbutamol Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Specialty Clinic
1.4.4 Treatment Center
1.4.5 Others
1.5 Global Salbutamol Injection Market Size & Forecast
1.5.1 Global Salbutamol Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Salbutamol Injection Sales Quantity (2018-2029)
1.5.3 Global Salbutamol Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Teva Pharmaceuticals
2.1.1 Teva Pharmaceuticals Details
2.1.2 Teva Pharmaceuticals Major Business
2.1.3 Teva Pharmaceuticals Salbutamol Injection Product and Services
2.1.4 Teva Pharmaceuticals Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Pharmaceuticals Recent Developments/Updates
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Salbutamol Injection Product and Services
2.2.4 Mylan Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mylan Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Salbutamol Injection Product and Services
2.3.4 Novartis Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Salbutamol Injection Product and Services
2.4.4 Pfizer Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Salbutamol Injection Product and Services
2.5.4 Sanofi Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments/Updates
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Salbutamol Injection Product and Services
2.6.4 Merck Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Recent Developments/Updates
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Salbutamol Injection Product and Services
2.7.4 Johnson & Johnson Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson & Johnson Recent Developments/Updates
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Salbutamol Injection Product and Services
2.8.4 Roche Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Recent Developments/Updates
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline Salbutamol Injection Product and Services
2.9.4 GlaxoSmithKline Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GlaxoSmithKline Recent Developments/Updates
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Salbutamol Injection Product and Services
2.10.4 AstraZeneca Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AstraZeneca Recent Developments/Updates
2.11 Abbott Laboratories
2.11.1 Abbott Laboratories Details
2.11.2 Abbott Laboratories Major Business
2.11.3 Abbott Laboratories Salbutamol Injection Product and Services
2.11.4 Abbott Laboratories Salbutamol Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Abbott Laboratories Recent Developments/Updates
3 Competitive Environment: Salbutamol Injection by Manufacturer
3.1 Global Salbutamol Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Salbutamol Injection Revenue by Manufacturer (2018-2023)
3.3 Global Salbutamol Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Salbutamol Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Salbutamol Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Salbutamol Injection Manufacturer Market Share in 2022
3.5 Salbutamol Injection Market: Overall Company Footprint Analysis
3.5.1 Salbutamol Injection Market: Region Footprint
3.5.2 Salbutamol Injection Market: Company Product Type Footprint
3.5.3 Salbutamol Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Salbutamol Injection Market Size by Region
4.1.1 Global Salbutamol Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Salbutamol Injection Consumption Value by Region (2018-2029)
4.1.3 Global Salbutamol Injection Average Price by Region (2018-2029)
4.2 North America Salbutamol Injection Consumption Value (2018-2029)
4.3 Europe Salbutamol Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Salbutamol Injection Consumption Value (2018-2029)
4.5 South America Salbutamol Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Salbutamol Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Salbutamol Injection Sales Quantity by Type (2018-2029)
5.2 Global Salbutamol Injection Consumption Value by Type (2018-2029)
5.3 Global Salbutamol Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Salbutamol Injection Sales Quantity by Application (2018-2029)
6.2 Global Salbutamol Injection Consumption Value by Application (2018-2029)
6.3 Global Salbutamol Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Salbutamol Injection Sales Quantity by Type (2018-2029)
7.2 North America Salbutamol Injection Sales Quantity by Application (2018-2029)
7.3 North America Salbutamol Injection Market Size by Country
7.3.1 North America Salbutamol Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Salbutamol Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Salbutamol Injection Sales Quantity by Type (2018-2029)
8.2 Europe Salbutamol Injection Sales Quantity by Application (2018-2029)
8.3 Europe Salbutamol Injection Market Size by Country
8.3.1 Europe Salbutamol Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Salbutamol Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Salbutamol Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Salbutamol Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Salbutamol Injection Market Size by Region
9.3.1 Asia-Pacific Salbutamol Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Salbutamol Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Salbutamol Injection Sales Quantity by Type (2018-2029)
10.2 South America Salbutamol Injection Sales Quantity by Application (2018-2029)
10.3 South America Salbutamol Injection Market Size by Country
10.3.1 South America Salbutamol Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Salbutamol Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Salbutamol Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Salbutamol Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Salbutamol Injection Market Size by Country
11.3.1 Middle East & Africa Salbutamol Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Salbutamol Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Salbutamol Injection Market Drivers
12.2 Salbutamol Injection Market Restraints
12.3 Salbutamol Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Salbutamol Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Salbutamol Injection
13.3 Salbutamol Injection Production Process
13.4 Salbutamol Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Salbutamol Injection Typical Distributors
14.3 Salbutamol Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Salbutamol Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Salbutamol Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Teva Pharmaceuticals Major Business
Table 5. Teva Pharmaceuticals Salbutamol Injection Product and Services
Table 6. Teva Pharmaceuticals Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Teva Pharmaceuticals Recent Developments/Updates
Table 8. Mylan Basic Information, Manufacturing Base and Competitors
Table 9. Mylan Major Business
Table 10. Mylan Salbutamol Injection Product and Services
Table 11. Mylan Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Mylan Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Salbutamol Injection Product and Services
Table 16. Novartis Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Salbutamol Injection Product and Services
Table 21. Pfizer Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Salbutamol Injection Product and Services
Table 26. Sanofi Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi Recent Developments/Updates
Table 28. Merck Basic Information, Manufacturing Base and Competitors
Table 29. Merck Major Business
Table 30. Merck Salbutamol Injection Product and Services
Table 31. Merck Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Merck Recent Developments/Updates
Table 33. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 34. Johnson & Johnson Major Business
Table 35. Johnson & Johnson Salbutamol Injection Product and Services
Table 36. Johnson & Johnson Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Johnson & Johnson Recent Developments/Updates
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Major Business
Table 40. Roche Salbutamol Injection Product and Services
Table 41. Roche Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Roche Recent Developments/Updates
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Major Business
Table 45. GlaxoSmithKline Salbutamol Injection Product and Services
Table 46. GlaxoSmithKline Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. GlaxoSmithKline Recent Developments/Updates
Table 48. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 49. AstraZeneca Major Business
Table 50. AstraZeneca Salbutamol Injection Product and Services
Table 51. AstraZeneca Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 54. Abbott Laboratories Major Business
Table 55. Abbott Laboratories Salbutamol Injection Product and Services
Table 56. Abbott Laboratories Salbutamol Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Abbott Laboratories Recent Developments/Updates
Table 58. Global Salbutamol Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Salbutamol Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Salbutamol Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Salbutamol Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Salbutamol Injection Production Site of Key Manufacturer
Table 63. Salbutamol Injection Market: Company Product Type Footprint
Table 64. Salbutamol Injection Market: Company Product Application Footprint
Table 65. Salbutamol Injection New Market Entrants and Barriers to Market Entry
Table 66. Salbutamol Injection Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Salbutamol Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Salbutamol Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Salbutamol Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Salbutamol Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Salbutamol Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Salbutamol Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Salbutamol Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Salbutamol Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Salbutamol Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Salbutamol Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Salbutamol Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Salbutamol Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Salbutamol Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Salbutamol Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Salbutamol Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Salbutamol Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Salbutamol Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Salbutamol Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Salbutamol Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Salbutamol Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Salbutamol Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Salbutamol Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Salbutamol Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Salbutamol Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Salbutamol Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Salbutamol Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Salbutamol Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Salbutamol Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Salbutamol Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Salbutamol Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Salbutamol Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Salbutamol Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Salbutamol Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Salbutamol Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Salbutamol Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Salbutamol Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Salbutamol Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Salbutamol Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Salbutamol Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Salbutamol Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Salbutamol Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Salbutamol Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Salbutamol Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Salbutamol Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Salbutamol Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Salbutamol Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Salbutamol Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Salbutamol Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Salbutamol Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Salbutamol Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Salbutamol Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Salbutamol Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Salbutamol Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Salbutamol Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Salbutamol Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Salbutamol Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Salbutamol Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Salbutamol Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Salbutamol Injection Raw Material
Table 126. Key Manufacturers of Salbutamol Injection Raw Materials
Table 127. Salbutamol Injection Typical Distributors
Table 128. Salbutamol Injection Typical Customers
List of Figures
Figure 1. Salbutamol Injection Picture
Figure 2. Global Salbutamol Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Salbutamol Injection Consumption Value Market Share by Type in 2022
Figure 4. Salbutamol Sulfate Injection Examples
Figure 5. Salbutamol and Ipratropium Bromide Injection Examples
Figure 6. Global Salbutamol Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Salbutamol Injection Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Specialty Clinic Examples
Figure 10. Treatment Center Examples
Figure 11. Others Examples
Figure 12. Global Salbutamol Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Salbutamol Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Salbutamol Injection Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Salbutamol Injection Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Salbutamol Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Salbutamol Injection Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Salbutamol Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Salbutamol Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Salbutamol Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Salbutamol Injection Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Salbutamol Injection Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Salbutamol Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Salbutamol Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Salbutamol Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Salbutamol Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Salbutamol Injection Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Salbutamol Injection Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Salbutamol Injection Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Salbutamol Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Salbutamol Injection Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Salbutamol Injection Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Salbutamol Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Salbutamol Injection Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Salbutamol Injection Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Salbutamol Injection Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Salbutamol Injection Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Salbutamol Injection Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Salbutamol Injection Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Salbutamol Injection Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Salbutamol Injection Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Salbutamol Injection Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Salbutamol Injection Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Salbutamol Injection Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Salbutamol Injection Consumption Value Market Share by Region (2018-2029)
Figure 54. China Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Salbutamol Injection Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Salbutamol Injection Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Salbutamol Injection Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Salbutamol Injection Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Salbutamol Injection Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Salbutamol Injection Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Salbutamol Injection Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Salbutamol Injection Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Salbutamol Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Salbutamol Injection Market Drivers
Figure 75. Salbutamol Injection Market Restraints
Figure 76. Salbutamol Injection Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Salbutamol Injection in 2022
Figure 79. Manufacturing Process Analysis of Salbutamol Injection
Figure 80. Salbutamol Injection Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source